GSE119290
Expression-based drug screening of neural progenitor cells from individuals with schizophrenia [RNA-seq]
Integration of in silico and in vitro approaches to design and conduct transcriptomic drug screening in patient-derived neural cells, in order to survey novel pathologies and points of intervention in schizophrenia. Overall design: RNA-sequencing from